Sterol regulatory element-binding proteins and reactive oxygen species: potential role in highly-active antiretroviral therapy (HAART)-associated lipodystrophy (Q34460031)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Sterol regulatory element-binding proteins and reactive oxygen species: potential role in highly-active antiretroviral therapy (HAART)-associated lipodystrophy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

Sterol regulatory element-binding proteins and reactive oxygen species: potential role in highly-active antiretroviral therapy (HAART)-associated lipodystrophy (English)

1 reference

Europe PubMed Central

2 August 2017

reactive oxygen species

1 reference

based on heuristic

inferred from title

author name string

P V Nerurkar

1

1 reference

Europe PubMed Central

2 August 2017

C M Shikuma

2

1 reference

Europe PubMed Central

2 August 2017

V R Nerurkar

3

1 reference

Europe PubMed Central

2 August 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

2 August 2017

Clinical Biochemistry

1 reference

Europe PubMed Central

2 August 2017

34

1 reference

Europe PubMed Central

2 August 2017

7

1 reference

Europe PubMed Central

2 August 2017

519-529

1 reference

Europe PubMed Central

2 August 2017

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Indinavir-associated lipodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Facilitative glucose transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Insulin resistance in HIV protease inhibitor-associated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Influence of protease inhibitor therapy on lipoprotein metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Fat distribution and metabolic changes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

"Buffalo hump" in men with HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Visceral abdominal-fat accumulation associated with use of indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Studies on the inhibition of mitochondrial DNA replication by 3'-azido-3'-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Understanding adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Depot-related gene expression in human subcutaneous and omental adipocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Steroid hormone receptors in human adipose tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Molecular regulation of adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Mouse insulin-responsive glucose transporter gene: characterization of the gene and trans-activation by the CCAAT/enhancer binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Expression of the differentiation-induced gene for fatty acid-binding protein is activated by glucocorticoid and cAMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARgamma/RXR heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Dietary regulation of gene expression: enzymes involved in carbohydrate and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Effect of human immunodeficiency virus type 1 on intracellular activation and superoxide production by neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Molecular mechanism of the short-term cardiotoxicity caused by 2',3'-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Evaluation of oxidative stress in patients with hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

With medium-chain triglycerides, higher and faster oxygen radical production by stimulated polymorphonuclear leukocytes occurs

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Increased generation of reactive oxygen species in mononuclear blood cells from hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Role of oxidant stress and iron delocalization in acidosis-induced intestinal epithelial hyperpermeability

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Ultrastructural changes associated with reduced mitochondrial DNA and impaired mitochondrial function in the presence of 2'3'-dideoxycytidine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Oxidants as stimulators of signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

The role of intracellular oxidants in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Bcl-2 functions in an antioxidant pathway to prevent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of serum samples from patients infected with HIV: elevated lipid hydroperoxide concentrations and depleted total antioxidant capacity of serum samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2801%2900239-9

7 January 2021

Identifiers

10.1016/S0009-9120(01)00239-9

1 reference

Europe PubMed Central

2 August 2017

release_vktszig24vbvnksj326pfezwqe

1 reference

https://api.fatcat.wiki/v0/release/vktszig24vbvnksj326pfezwqe

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34460031&oldid=2042193210"